by jenerasmus | Dec 2, 2021 | Blog
Adaptive trial designs emerged as a means to improve clinical trials based on all available information. High failure rates and increasing costs have driven the industry toward adaptive trial designs. In The Adaptive Designs for Clinical Trials of Drugs and Biologics...
by jenerasmus | Nov 18, 2021 | Blog
November is Lung Cancer Awareness Month, an annual global observance designed to raise people’s awareness of lung cancer and how to prevent, detect, or treat it. Lung cancer is the most common cause of cancer death in the United States and worldwide,...
by jenerasmus | Nov 11, 2021 | Blog
Introduction Real-Word Data (RWD) and Real-World Evidence (RWE) are acronyms that have been thrown around the industry for some time. As healthcare, life sciences companies and regulators look at the potential research opportunities that...
by jenerasmus | Oct 26, 2021 | Blog
October is Breast Cancer Awareness Month. The National Breast Cancer Foundation estimates one in eight women in the United States will be diagnosed with breast cancer in her lifetime.1 Most of us know a friend or family member who has faced a diagnosis of breast...
by jenerasmus | Oct 7, 2021 | Blog
For those who attended the SCDM Live Global Conference, the futuristic style of the virtual meeting and the theme (Future Now: v.2.021) did not disappoint. The conference last week broke attendance records with 1650 attendees from around the world. There were ample...
